Brief: Vaxil Commences Preclinical COVID-19 Vaccine Trial And Files An Additional COVID-19 Patent
27/03/2020 13:11
March 27 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL COMMENCES PRECLINICAL COVID-19 VACCINE TRIAL AND
FILES AN
ADDITIONAL COVID-19 PATENT
Source text for Eikon: ID:nGNX5sFr5l
Further company coverage: VXL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxil Bio
See all newsBrief: Vaxil Announces Close Of Previously Announced Non-Brokered Private Placement
Brief: Vaxil Bio Says Proposed Reverse Takeover With Green Date Terminated
Brief: Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
Brief: Vaxil Bio To Continue Actively Explore Other Strategic Options
Brief: Vaxil Bio Enters Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover